Formation of a Human β-Cell Population within Pancreatic Islets Is Set Early in Life
Open accessThe DOI matches its Crossref record; 43 of the 50 references it cites were found in a registry or an index.
Abstract
CONTEXT: Insulin resistance can be compensated by increased functional pancreatic β-cell mass; otherwise, diabetes ensues. Such compensation depends not only on environmental and genetic factors but also on the baseline β-cell mass from which the expansion originates. OBJECTIVE: Little is known about assembly of a baseline β-cell mass in humans. Here, we examined formation of β-cell populations relative to other pancreatic islet cell types and associated neurons throughout the normal human lifespan. DESIGN AND METHODS: Human pancreatic sections derived from normal cadavers aged 24 wk premature to 72 yr were examined by immunofluorescence. Insulin, glucagon, and somatostatin were used as markers for β-, α-, and δ-cells, respectively. Cytokeratin-19 marked ductal cells, Ki67 cell proliferation, and Tuj1 (neuronal class III β-tubulin) marked neurons. RESULTS: Most β-cell neogenesis was observed preterm with a burst of β-cell proliferation peaking within the first 2 yr of life. Thereafter, little indication of β-cell growth was observed. Postnatal proliferation of α- and δ-cells was rarely seen, but a wave of ductal cell proliferation was found mostly associated with exocrine cell expansion. The β-cell to α-cell ratio doubled neonatally, reflecting increased growth of β-cells, but during childhood, there was a 7-fold change in the β-cell to δ-cell ratio, reflecting an additional loss of δ-cells. A close association of neurons to pancreatic islets was noted developmentally and retained throughout adulthood. Negligible neuronal association to exocrine pancreas was observed. CONCLUSION: Human baseline β-cell population and appropriate association with other islet cell types is established before 5 yr of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both of these concepts of pathogenesis of type 1 diabetes have been debated.50,51”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent data suggest that although most patients with longstanding type 1 diabetes have few β cells, if any, there is evidence for β-cell regeneration in infants and very young children (but not in adolescents or adults).51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-Cell mass increases during the first decade of life due to proliferation during the first 5 years ( 53 , 54 ), stabilizing during adolescence with considerable variation (three- to fivefold) unrelated to age or BMI.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [53]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these and other studies, analyses of pancreata from individuals with recent-onset type 1 diabetes suggest that around 70% of islets display complete insulin absence;51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Self-citationBrissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
Intrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat
Simmons, R. A., Templeton, L. J., & Gertz, S. J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2279 · Cited by 638
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Brissova, M., Shostak, A., Shiota, M., Wiebe, P. O., Poffenberger, G., Kantz, J., Chen, Z., Carr, C., Jerome, W. G., Chen, J., et al. (2006) · Diabetes · doi:10.2337/db06-0690 · Cited by 442
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., & Butler, P. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1809-6 · Cited by 435
Studies on the pancreas of the guinea pig
Bensley, R. R. (1911) · American Journal of Anatomy · doi:10.1002/aja.1000120304 · Cited by 426
Cited by
Items 101–200 of 344
Mohan, R., Baumann, D. C., & Alejandro, E. U. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00072.2018 · Cited by 53
Campbell-Thompson, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12286 · Cited by 46
“Normal islet sizes are highly variable with a mean diameter of ∼135 μm, ranging from 6 to 10 cells depending on the study criteria, up to 250 μm (41, 42).”
BackgroundArroyave, F., Montaño, D., & Lizcano, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228685 · Cited by 62
“Many differences among pancreatic islets in animals relative to humans and molecular and epigenetic changes observed when β-cells reach maturation have challenged this practice [143].”
BackgroundSpears, E., Serafimidis, I., Powers, A. C., & Gavalas, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.722250 · Cited by 53
Life course health care and preemptive approach to non-communicable diseases
Imura, H. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.462 · Cited by 53
New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation
Pugliese, A., Vendrame, F., Reijonen, H., Atkinson, M. A., Campbell-Thompson, M., & Burke, G. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0530-0 · Cited by 45
Self-citationThe regulation of pre- and post-maturational plasticity of mammalian islet cell mass
Mezza, T., & Kulkarni, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3251-7 · Cited by 48
“Decline in beta cell function; decline in beta cell replication Beta cell mass remains relatively constant in healthy humans [121] No major alterations in beta cell size [120] Beta cell apoptosis is low and remains constant throughout life [21] In diabetes: Mitochondrial dysfunction, oxidative stress, ER stress and ac…”
BackgroundMethodInfluentialPetersen, M. B. K., Gonçalves, C. A., Kim, Y. H., & Grapin‐Botton, A. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.009 · Cited by 53
Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases
Yang, Y., Fan, X., Liu, Y., Ye, D., Liu, C., Yang, H., Su, Z., Zhang, Y., & Liu, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115521 · Cited by 46
Johnson, M. B., Patel, K., Franco, E. D., Hagopian, W., Killian, M., McDonald, T. J., Tree, T. I. M., Domingo‐Vila, C., Hudson, M., Hammersley, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05276-4 · Cited by 47
“This may be particularly relevant to our cohort given that the expansion of beta cell mass in humans is limited to very early life [35].”
BackgroundJiang, L., Shen, Y., Liu, Y., Zhang, L. J., & Jiang, W. (2022) · Theranostics · doi:10.7150/thno.66670 · Cited by 49
“The β- to α-cell ratio increased 6- to 7-fold from developmental preterm to childhood [164], and the β- to α-cell ratio in small size islets (defined as 40–60 μm in diameter) is nearly double of that in large size islets (> 300 μm in diameter) [165].”
BackgroundZung, A., Kori, M., Burundukov, E., Ben‐Yosef, T., Tatoor, Y., & Granot, E. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37341 · Cited by 41
“The clinical recovery by no means suggests regeneration of b-cells, since b-cells do not proliferate much after early childhood in humans [Gregg et al., 2012].”
BackgroundCantú-Rodríguez, O. G., Lavalle-González, F., Herrera-Rojas, M. Á., Jaime-Pérez, J. C., Hawing-Zárate, J. Á., Gutiérrez-Aguirre, C. H., Mancias-Guerra, C., González-Llano, O., Zapata-Garrido, A., Villarreal-Pérez, J. Z., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2776 · Cited by 39
Replicative capacity of β-cells and type 1 diabetes
Saunders, D. C., & Powers, A. C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.03.014 · Cited by 42
“In humans, an increase in β-cell proliferation has been noted soon after birth and in the first 2–3 years of life [2] with the β-cell proliferation rate declining within and after the first decade of life and thereafter remaining low in the adult period (Figure 2).”
BackgroundDeterminants and dynamics of pancreatic islet architecture
Adams, M. T., & Blum, B. (2022) · Islets · doi:10.1080/19382014.2022.2030649 · Cited by 48
“Interestingly, it appears that human islets develop first with a mantle-core architecture like that of rodent islets, which is replaced by the intercalating α-β cell architecture of the human islet during the first months of postnatal life.(41,42) Though there have been several hypotheses put forth to explain the 84 M.”
BackgroundDisrupting the DREAM complex enables proliferation of adult human pancreatic β cells
Wang, P., Karaköse, E., Argmann, C., Wang, H., Balev, M., Brody, R., Rivas, H. G., Liu, X., Wood, O., Liu, H., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157086 · Cited by 37
“This replicative refractoriness has been attributed variously to multiple processes including: chromatin configurations and/or DNA methylation patterns that enforce quiescence through repression of D-cyclin and CDK genes (7,33-35,46,47,51); activation of cell cycle inhibitors, notably p16INK4A encoded by CDKN2A and p5…”
Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes
Cerf, M. E. (2013) · Endocrine · doi:10.1007/s12020-013-9917-y · Cited by 42
Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children
Henquin, J.-C., & Nenquin, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165961 · Cited by 37
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Yuan, T., Rafizadeh, S., Azizi, Z., Lupše, B., Gorrepati, K. D. D., Awal, S., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · JCI Insight · doi:10.1172/jci.insight.86326 · Cited by 43
Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy
Simeoli, R., & Fierabracci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184627 · Cited by 38
“Another important aspect is that, in patients with longstanding disease, the remaining pancreatic β-cells resistant to autoimmune destruction are incapable of regeneration [3].”
BackgroundResultAamodt, K. I., Aramandla, R., Brown, J. J., Fiaschi‐Taesch, N., Wang, P., Stewart, A. F., Briššová, M., & Powers, A. C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00515.2015 · Cited by 38
“Studies of the human pancreas have found that -cell proliferation peaks neonatally at 1–3% and then sharply declines after the first year of life eventually approaching near 0% and remains at this low level throughout adulthood (17, 21, 24, 27).”
BackgroundPancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Tanday, N., Tarasov, A. I., Moffett, R. C., Flatt, P. R., & Irwin, N. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15300 · Cited by 40
“21 The proliferation persists throughout gestation and is sustained after birth, before declining from about 3 years of age.”
BackgroundPan, Y., Yuan, S., Teng, Y., Zeng, Z., He, Y., Zhang, Y., Liang, H., Wu, X., Li, J., Yang, H., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.044 · Cited by 43
Stewart, A. F. (2014) · Diabetes · doi:10.2337/db14-0009 · Cited by 35
Islet Number Rather Than Islet Size Is a Major Determinant of β- and α-Cell Mass in Humans
Kou, K., Saisho, Y., Sato, S., Yamada, T., & Itoh, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3731 · Cited by 41
Hsueh, B., Burns, V. M., Pauerstein, P. T., Holzem, K. M., Li, Y., Engberg, K., Wang, A.-C., Gu, X., Chakravarthy, H., Arda, H. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05614-4 · Cited by 36
SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism
Lithovius, V., Saarimäki-Vire, J., Balboa, D., Ibrahim, H., Montaser, H., Barsby, T., & Otonkoski, T. (2021) · Diabetologia · doi:10.1007/s00125-020-05346-7 · Cited by 35
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
Rohli, K. E., Boyer, C. K., Blom, S. E., & Stephens, S. B. (2022) · Biomolecules · doi:10.3390/biom12020335 · Cited by 41
Advances in drug discovery for human beta cell regeneration
Karaköse, E., Ackeifi, C. A., Wang, P., & Stewart, A. F. (2018) · Diabetologia · doi:10.1007/s00125-018-4639-6 · Cited by 34
Greeley, S. A. W., Zielinski, M. C., Poudel, A., Ye, H., Berry, S., Taxy, J. B., Carmody, D., Steiner, D. F., Philipson, L. H., Wood, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2826 · Cited by 33
“4), in contrast to a reported increase in similarly aged children (7).”
ResultTang, X., Kusmartseva, I., Kulkarni, S., Posgai, A. L., Speier, S., Schatz, D. A., Haller, M. J., Campbell‐Thompson, M., Wasserfall, C. H., Roep, B. O., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.010 · Cited by 35
Self-citationGolson, M. L., Dunn, J. C., Maulis, M. F., Dadi, P. K., Osipovich, A. B., Magnuson, M. A., Jacobson, D. A., & GANNON, M. A. (2015) · Diabetes · doi:10.2337/db15-0465 · Cited by 36
“increased incidence of diabetes with age inversely correlates with β-cell proliferation (5-7), the primary mechanism for increasing β-cell mass after early postnatal life (5; 8).”
BackgroundThe postnatal pancreatic microenvironment guides β cell maturation through BMP4 production
Sakhneny, L., Mueller, L. M., Schonblum, A., Azaria, S., Burganova, G., Epshtein, A., Isaacson, A., WILSON, H. M., Spagnoli, F. M., & Landsman, L. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.08.014 · Cited by 35
Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development
Hill, J. H., Bell, R. S., Barrios, L., Baird, H., Ost, K. S., Greenewood, M., Monts, J., Tracy, E., Meili, C. H., Chiaro, T. R., et al. (2025) · Science · doi:10.1126/science.adn0953 · Cited by 32
Neonatal pancreatic pericytes support β-cell proliferation
Epshtein, A., Rachi, E., Sakhneny, L., Mizrachi, S., Baer, D., & Landsman, L. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.010 · Cited by 34
Understanding generation and regeneration of pancreatic β cells from a single-cell perspective
Yu, X., & Xu, C. (2020) · Development · doi:10.1242/dev.179051 · Cited by 34
“β Cells undergo a burst in proliferation during the early postnatal period, followed by a decrease in proliferation and functional maturation (Finegood et al., 1995; Meier et al., 2008; Gregg et al., 2012).”
BackgroundSingh, S. P., Janjuha, S., Chaudhuri, S., Reinhardt, S., Kränkel, A., Dietz, S., Eugster, A., Bilgin, H., Korkmaz, S., Zararsız, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35218-5 · Cited by 29
Islet Regeneration: Endogenous and Exogenous Approaches
Docherty, F. M., & Sussel, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073306 · Cited by 31
“In basal conditions, the postnatal expansion of the human beta cell population continues, largely through proliferation, and peaks around two years of age [18].”
BackgroundA complex auxiliary: IL-17/Th17 signaling during type 1 diabetes progression
Zheng, Z., & Zheng, F. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.11.007 · Cited by 29
The many lives of Myc in the pancreatic β-cell
Rosselot, C., Baumel-Alterzon, S., Li, Y., Brill, G., Lambertini, L., Katz, L. S., Lu, G., García-Ocaña, A., & Scott, D. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011149 · Cited by 37
“Normal adult β-cells have intrinsically low proliferative rates that correlate with low Myc expression levels (5, 6, 22, 33, 74, 91).”
BackgroundCastell, A., Éthier, M., Fergusson, G., Tremblay, C. C., Goubault, C., Baltz, M., Soglio, D. B. D., Ghislain, J. J., & Poitout, V. (2022) · JCI Insight · doi:10.1172/jci.insight.160854 · Cited by 32
“Although limited evidence suggests that β cell replication increases in humans during puberty (19, 20), the mechanisms controlling β cell proliferation in the face of pubertal insulin resistance remain largely unexplored.”
BackgroundCaballero, F., Siniakowicz, K., Hollister‐Lock, J., Duran, L., Katsuta, H., Yamada, T., Lei, J., Deng, S., Westermark, G. T., Markmann, J. F., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x659916 · Cited by 27
“In humans, b-cell replication in most adult pancreas appears to be negligible (4,6,8,17), and there is evidence for some neogenesis (1,3).”
Tiwari, S., Roel, C., Wills, R. C., Casinelli, G. P., Tanwir, M., Takane, K. K., & Fiaschi‐Taesch, N. (2015) · Diabetes · doi:10.2337/db14-1885 · Cited by 29
Raff, H., Hoeynck, B., Jablonski, M., Leonovicz, C., Phillips, J. M., & Gehrand, A. L. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00271.2017 · Cited by 32
New Aspects of Diabetes Research and Therapeutic Development
Satin, L. S., Soleimanpour, S. A., & Walker, E. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000160 · Cited by 34
Gehrand, A. L., Hoeynck, B., Jablonski, M., Leonovicz, C., Ye, R., Scherer, P. E., & Raff, H. (2016) · Physiological Reports · doi:10.14814/phy2.12972 · Cited by 25
“Of interest is that human beta cell populations are established preterm, and peak within the first 2 years of life (Gregg et al. 2012).”
BackgroundMesenchymal Stem Cells Ameliorate Hyperglycemia in Type I Diabetic Developing Male Rats
Yousef, H. N., Sakr, S. M., & Sabry, S. A. (2022) · Stem Cells International · doi:10.1155/2022/7556278 · Cited by 29
“[65] who stated that proliferation of β cells in humans occurs only during early childhood.”
BackgroundVirgin β-Cells at the Neogenic Niche Proliferate Normally and Mature Slowly
Lee, S. C. L., Zhang, J., Saravanakumar, S., Flisher, M. F., Grimm, D. R., van der Meulen, T., & Huising, M. O. (2021) · Diabetes · doi:10.2337/db20-0679 · Cited by 25
“However, b-cell proliferation declines rapidly with age in mice (8–10), with even lower proliferation rates observed in human islets (11), which complicates the challenge of restoring b-cell mass secondary to diabetesassociated b-cell loss.”
BackgroundFrom immunobiology to β-cell biology: The changing perspective on type 1 diabetes
Maganti, A. V., Evans‐Molina, C., & Mirmira, R. G. (2014) · Islets · doi:10.4161/isl.28778 · Cited by 24
Expression mechanism of tryptophan hydroxylase 1 in mouse islets during pregnancy
Iida, H., Ogihara, T., Min, M.-K., Hara, A., Kim, Y. G., Fujimaki, K., Tamaki, M., Fujitani, Y., Kim, H., & Watada, H. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0299 · Cited by 24
“Whereas islet mass increases during the prenatal and neonatal period, the appearance of proliferation markers in b cells decreases with ageing (Meier et al. 2005, 2008, Gregg et al. 2012, Saisho et al. 2013).”
BackgroundSato, S., Saisho, Y., Inaishi, J., Kou, K., Murakami, R., Yamada, T., & Itoh, H. (2015) · Diabetes · doi:10.2337/db15-0151 · Cited by 24
CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats
Sacaan, A. I., Thibault, S., Hong, M., Kondegowda, N. G., Nichols, T., Li, R., Rosselot, C., Evering, W., Fenutría, R., Vitsky, A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0172 · Cited by 23
Insulin Is Transcribed and Translated in Mammalian Taste Bud Cells
Doyle, M. E., Fiori, J. L., González‐Mariscal, I., Liu, Q., Goodstein, E., Yang, H., Shin, Y., Calvo, S. S.-C., Indig, F. E., & Egan, J. M. (2018) · Endocrinology · doi:10.1210/en.2018-00534 · Cited by 22
Multimodal Nanoprobe for Pancreatic Beta Cell Detection and Amyloidosis Mitigation
Xin, F., Li, Y., Fu, C., Javed, I., Huang, X., Schaschkow, A., Ribeiro, R. S. G., Gurzov, E. N., Davis, T. P., Zhang, X., et al. (2020) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b03841 · Cited by 23
Pancreatic β cell regeneration: to β or not to β
Guney, M. A., Lorberbaum, D. S., & Sussel, L. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.10.019 · Cited by 27
Tatsuoka, H., Sakamoto, S., Yabe, D., Kabai, R., Kato, U., Okumura, T., Botagarova, A., Tokumoto, S., Usui, R., Ogura, M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101774 · Cited by 22
“However, replication rate of b-cells in adult human and mice is extremely low (Butler et al., 2003; Reers et al., 2009; Teta et al., 2005) as a result of its gradual decrease with aging from highest replication after birth (Gregg et al., 2012; Teta et al., 2005).”
BackgroundDrotar, D. M., Ramos, G. J. A. V., Williams, M. D., David, S. T., Luce, C., Smith, J. A., Posgai, A. L., Bacher, R. L., Campbell‐Thompson, M., Kusmartseva, I., et al. (2025) · Diabetes · doi:10.2337/db25-0326 · Cited by 22
Self-citationDefinition of a Skp2-c-Myc Pathway to Expand Human Beta-cells
Tiwari, S., Roel, C., Tanwir, M., Wills, R. C., Perianayagam, N., Wang, P., & Fiaschi‐Taesch, N. (2016) · Scientific Reports · doi:10.1038/srep28461 · Cited by 21
Human Islet Isolation and Distribution Efforts for Clinical and Basic Research
Ng, N. H. J., Tan, W. X., Koh, Y. X., & Teo, A. K. K. (2019) · OBM Transplantation · doi:10.21926/obm.transplant.1902068 · Cited by 25
Akhaphong, B., Lockridge, A. D., Jo, S., Mohan, R., Wilcox, J. A., Wing, C. R., Regal, J. F., & Alejandro, E. U. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00458.2017 · Cited by 21
Molecular and functional profiling of human islets: from heterogeneity to human phenotypes
Drigo, R. A. E., Roy, B., & MacDonald, P. E. (2020) · Diabetologia · doi:10.1007/s00125-020-05159-8 · Cited by 24
Small things matter: Lack of extraislet β cells in type 1 diabetes
Murrall, K., Luckett, T., Lekka, C., Flaxman, C. S., Wyatt, R. C., Akhbari, P., Kusmartseva, I., Hunter, S. L., Leete, P., Burn, I., et al. (2025) · Science Advances · doi:10.1126/sciadv.adz2251 · Cited by 38
“Debate as to whether this sustained increase in endocrine mass, especially beyond the age of 10 years, is derived from endocrine proliferation or neogenesis is ongoing ( 20 , 45 – 49 ).”
Acinar to β-like cell conversion through inhibition of focal adhesion kinase
Dahiya, S., Saleh, M. W., Rodriguez, U. A., Rajasundaram, D., Arbujas, J. R., Hajihassani, A., Yang, K., Sehrawat, A., Kalsi, R. S., Yoshida, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47972-4 · Cited by 23
Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia
Lee, J., & Yoon, K. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2193 · Cited by 22
“After reaching adulthood, β-cell mass remains plastic, making puberty the last period in which one can significantly increase β-cell mass under physiological conditions, aside from pregnancy [50-53].”
Meng, G., Gu, J., Liew, S. Y., Cao, J., Wang, Z., Ma, C., Fu, Z., Zhou, H., Wang, J., Wang, S., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.07.006 · Cited by 23
Tenenbaum, M., Plaisance, V., Boutry, R., Pawlowski, V., Jacovetti, C., Sanchez-Parra, C., Ezanno, H., Bourry, J., Beeler, N., Pasquetti, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03499-7 · Cited by 19
Title, A. C., Karsai, M., Mir-Coll, J., Grining, Ö. Y., Rufer, C., Sonntag, S., Forschler, F., Jawurek, S., Klein, T., & Yesildag, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.854094 · Cited by 20
Impact of prematurity for pancreatic islet and beta-cell development
Bloomfield, F. H. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0021 · Cited by 22
Karaköse, E., Wang, X., Wang, P., Carcamo, S., Demircioğlu, D., Lambertini, L., Wood, O., Kang, R. B., Lu, G., Scott, D. K., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101832 · Cited by 27
“10, 38, 39 For example , the DYRK1A inhibitor inhibitor , increases beta cell mass in human islets transplanted Here, we report single-cell transcriptomics data for regenerative drug-treated human islets.”
Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans
Espes, D., Martinell, M., Liljebäck, H., & Carlsson, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0676-4 · Cited by 19
The undoing and redoing of the diabetic β-cell
Wang, W., Liu, C., Jiménez-González, M., Song, W., & Hussain, M. A. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.028 · Cited by 20
Evidence for a Neogenic Niche at the Periphery of Pancreatic Islets
Huising, M. O., Lee, S., & van der Meulen, T. (2018) · BioEssays · doi:10.1002/bies.201800119 · Cited by 18
Carlson, Z., Hafner, H., Mulcahy, M. C., Bullock, K. A., Zhu, A., Bridges, D., Bernal‐Mizrachi, E., & Gregg, B. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00473.2019 · Cited by 22
Self-citationLong‐term case study of a Wuzhishan miniature pig with diabetes
Niu, M., Liu, Y., Xiang, L., Zhao, Y., Yuan, J., Jia, Y., Dai, X., & Chen, H. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12098 · Cited by 20
SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells
Li, N., Zhang, S., Xiong, F., Eizirik, D. L., & Wang, C. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.008 · Cited by 18
Mitogen Synergy: An Emerging Route to Boosting Human Beta Cell Proliferation
Shcheglova, E. G., Błaszczyk, K., & Borowiak, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.734597 · Cited by 18
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes
Soldovieri, L., Giuseppe, G. D., Ciccarelli, G., Quero, G., Cinti, F., Brunetti, M., Nista, E. C., Gasbarrini, A., Alfieri, S., Pontecorvi, A., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101754 · Cited by 20
Lymphangiogenesis and angiogenesis during human fetal pancreas development
Roost, M. S., van Iperen, L., Bernardo, A. D. M., Mummery, C. L., Carlotti, F., de Koning, E. J. P., & Lopes, S. M. C. D. S. (2014) · Vascular Cell · doi:10.1186/2045-824x-6-22 · Cited by 19
“There are only a few studies addressing human pancreas development due to the restricted availability of human embryos [11-20].”
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies
Iheagwam, F. N., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 32
Prenatal development of sympathetic innervation of the human pancreas
Krivova, Y. S., Proshchina, A. E., Otlyga, D., Leonova, O. G., & Saveliev, S. V. (2021) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2021.151880 · Cited by 15
Baumel-Alterzon, S., Katz, L. S., Lambertini, L., Tse, I., Heidery, F., Garcı́a-Ocaña, A., & Scott, D. K. (2024) · Diabetologia · doi:10.1007/s00125-023-06071-7 · Cited by 15
A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
van Megen, K. M., Wout, E.-J. T. V. ’., Forman, S. J., & Roep, B. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00690 · Cited by 17
“β-Cell regeneration may occur until adolescence, after which regenerative capacity appears to stagnate (45).”
BackgroundDual Effect of Raptor on Neonatal β-Cell Proliferation and Identity Maintenance
Wang, Y., Sun, J., Ni, Q., Nie, A., Gu, Y., Wang, S., Zhang, W., Ning, G., Wang, W., & Wang, Q. (2019) · Diabetes · doi:10.2337/db19-0166 · Cited by 17
“It is widely accepted that establishment of adequate b-cell mass during the neonatal period (from prenatal to early postnatal) is essential for effective glucose control in adulthood (11,12).”
BackgroundCyclin D2is sufficient to drive β cell self-renewal and regeneration
Tschen, S.-I., Zeng, C., Field, L. J., Dhawan, S., Bhushan, A., & Georgia, S. K. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1319999 · Cited by 18
“In humans, b cell mass expansion is primarily driven by b cell self-renewal during childhood.(6) Although b cell self-renewal drops to very low levels in adulthood, it may be possible to exploit the pathways that regulate b cell self-renewal to drive therapeutic b cell expansion.”
BackgroundThe Role of the TGFβ Receptor Signaling Pathway in Adult Beta Cell Proliferation
Jiang, Y., Fischbach, S., & Xiao, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103136 · Cited by 15
“Significant increases in beta cell mass was observed to peak within the first 2 years of life, and then to rapidly decline in early childhood [10,11].”
BackgroundAssociations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
Sasaki, H., Saisho, Y., Inaishi, J., Watanabe, Y., Tsuchiya, T., Makio, M., Sato, M., Kitago, M., Yamada, T., & Itoh, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05127-2 · Cited by 17
Pancreatic endocrine cell arrangement during human ontogeny
Proshchina, A. E., Krivova, Y. S., Barabanov, V. M., & Saveliev, S. V. (2019) · Acta Histochemica · doi:10.1016/j.acthis.2019.05.010 · Cited by 16
Chernysheva, M. B., Ruchko, E. S., Karimova, M. V., Vorotelyak, E. A., & Vasiliev, А. V. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1424278 · Cited by 18
“Several studies have refuted the possibility of neogenesis in pancreatic regeneration, suggesting that this mechanism is dif fi cult to activate or is extremely rare (Lee et al., 2011; Gregg et al., 2012; Cavelti-Weder et al., 2013; Rankin et al., 2013; Liu et al., 2021).”
BackgroundInfluentialRevisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
Sasaki, H., Saisho, Y., Inaishi, J., & Itoh, H. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab128 · Cited by 18
“Interestingly, because both β-cell neogenesis and replication are highest in fetal life and decrease with age and β-cell apoptosis is rarely observed during growth, unlike the growth curve, β-cell growth is highest in infancy and decreases during adolescence and adulthood, with no secondary acceleration during puberty…”
BackgroundInfluentialAndersen, M. L. M., Nielsen, L. B., Svensson, J., Pörksen, S., Hougaard, P., Beam, C. A., Greenbaum, C. J., BECKER, D. J., Petersen, J. S., Hansen, L. B., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12098 · Cited by 13
“This finding suggests, and for the first time with in vivo data, that the regenerative/proliferative potential of β cells in humans is maximal ≤5 yr, an observation which is further supported by recent histological data showing that the human baseline β-cell population may indeed be established before 5 yr of age (28,…”
Neonatal Organ and Tissue Donation for Research: Options Following Death by Natural Causes
Anderson, M. W., Youngner, S. J., Smith, R. D., Nandyal, R. R., ORLOWSKI, J. P., Hill, B. J., & Barsman, S. G. (2020) · Cell and Tissue Banking · doi:10.1007/s10561-020-09822-7 · Cited by 15
Beta-cell function and human islet transplantation: can we improve?
Chen, J. H., & Gunton, J. E. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0590 · Cited by 16
“In humans, after the neonatal period, there is a sharp decrease in β -cell proliferation, with this being notably muted in adults at under 0.5% (Meier et al. 2008, Gregg et al. 2012).”
BackgroundInfluentialThe Potential of Pancreatic Organoids for Diabetes Research and Therapy
Bittenglová, K., Habart, D., Saudek, F., & Koblas, T. (2021) · Islets · doi:10.1080/19382014.2021.1941555 · Cited by 16
“108,109 In 1993, Bonner-Weir proposed two pathways of pancreas regeneration after 90% pancreatectomy in mice, when observing a) the replication of preexisting endocrine and exocrine cells, and b) the proliferation and differentiation of ductal cells, forming new lobules, which contained new beta…”
BackgroundHuman β-cell regeneration: progress, hurdles, and controversy
Jurczyk, A., Bortell, R., & Alonso, L. C. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000042 · Cited by 15
“In humans, one study found that the b-cell population is set early in life [4], but b-cell mass was also found to be preserved in aging [1].”
BackgroundStein, J. M., Milewski, W. M., & Dey, A. (2013) · Islets · doi:10.4161/isl.25605 · Cited by 15
“A, white [Glu]), suggesting an overall majority of β-cells than α-cells in adult human islets as also demonstrated by independent studies.(29) Likewise, when we examined the abundance of β- and α-cells in adult mouse islets, we found a typical β-cell core (Fig.”
ResultStewart, J. M., Posgai, A. L., Leon, J., Haller, M. J., & Keselowsky, B. G. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01075 · Cited by 13
“While triggering events that cause T1D onset and disease pathophysiology are still incompletely understood, β-cell loss is marked by a dramatic increase in infiltration of pancreatic islets by pathogenic CD4+ and CD8+ T cells as well as CD11c+ antigenpresenting cells (APCs) [2].”
BackgroundComplete remission of diabetes with a transient HDAC inhibitor and insulin in streptozotocin mice
Kojima, H., Katagi, M., Okano, J., Nakae, Y., Ohashi, N., Fujino, K., Miyazawa, I., & Nakagawa, T. (2023) · Communications Biology · doi:10.1038/s42003-023-05010-x · Cited by 12
Increasing β-Cell Mass Requires Additional Stimulation for Adaptation to Secretory Demand
Mondal, P., Song, W., Li, Y., Yang, K. S., & Hussain, M. A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1265 · Cited by 14
In vivo generation and regeneration of β cells in zebrafish
Yang, B., Covington, B. A., & Chen, W. (2020) · Cell Regeneration · doi:10.1186/s13619-020-00052-6 · Cited by 13
Repurposing Lesogaberan to Promote Human Islet Cell Survival andβ-Cell Replication
Tian, J., Dang, H. N., Hu, A., Xu, W., & Kaufman, D. L. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6403539 · Cited by 12
“The level of lesogaberan-induced β-cell replication in vivo was similar to that induced by GABA at the dosages used in our model and similar to the maximum level of β-cell replication that takes place shortly after birth in humans [37].”
Background
Metadata
- Authors
- Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J.
- Affiliations
- University of Chicago (US)
- The Kovler Diabetes Center (B.E.G., P.C.M., D.D., B.A.H., C.J.R.), Chicago, Illinois 60637
- University of Florida Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- 3197-3206
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3431572
- OpenAlex
- W2143050701
- Cited by
- 344
- References
- 50
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 20 · 2023: 23 · 2022: 26 · 2021: 31 · 2020: 26 · 2019: 25 · 2018: 26 · 2017: 23 · 2016: 26 · 2015: 33 · 2014: 21 · 2013: 18 · 2012: 1
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health (UL1TR000064)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 20595, DK-55267, R01DK055267, P60DK020595, P30DK020595)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell mass, beta-cell neogenesis, pancreatic islets, beta-cell proliferation, alpha cells, delta cells, somatostatin, glucagon, insulin, ductal cells, human lifespan, diabetes compensation, insulin resistance
- MeSH terms
- Adolescent, Adult, Aged, Autopsy, Cell Count, Child, Child, Preschool, Fluorescent Antibody Technique, Humans, Infant, Infant, Newborn, Infant, Premature, Islets of Langerhans, Middle Aged, Neurons, Pancreatic Hormones, Biomarkers, Paraffin Embedding, Pancreas, Exocrine, Cell Proliferation, Insulin-Secreting Cells, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.